Scott L. Greer
· Professor Health Management and Policy, Global Public Health, Political ScienceVerifiedUniversity of Michigan · Health Management and Policy
Active 1912–2025
About
Scott L. Greer, PhD, is a professor in the Health Management and Policy department at the University of Michigan School of Public Health. He is also a professor of Global Public Health and holds a courtesy appointment in Political Science. Dr. Greer is a political scientist whose research focuses on how political systems operate and influence health policy decisions. His work includes extensive research on topics such as COVID-19 policy response, health governance, strategic purchasing in healthcare, the politics of public health and disaster response, federalism, science policy, and European integration. He conducts research on the European Union, the United Kingdom, and the United States, and serves as a Senior Expert Advisor on Health Governance to the European Observatory on Health Systems and Policies. His research projects include qualitative studies on European Union health policy, comparative analyses of political systems and health policy decision-making during the COVID-19 pandemic across more than thirty countries, and investigations into the politics of healthy aging and intergenerational tensions related to healthcare costs.
Research topics
- Political Science
- Medicine
- Law
- Public administration
- Virology
- Economics
- Finance
- Geography
- Economic growth
- Political economy
- Sociology
- Public relations
- Development economics
- Computer Science
- Pathology
- Environmental health
- World Wide Web
- Psychology
- Advertising
- Mathematics
- Social psychology
- Business
Selected publications
International Journal of Health Policy and Management · 2025-07-14
articleOpen access1st authorCorrespondingStadhouders and colleagues' new measure answers an important question: Do strategic purchasing and managed competition redirect healthcare resources, and, if so, when, how, and to what? Applying it to the Netherlands, they find that they do not. This commentary first examines logical problems in arguments for strategic purchasing and managed competition, and then briefly reviews other evidence of their very limited success from, in particular, the Netherlands and England. It then raises the question of why strategic purchasing and managed competition continue to be advocated despite the poor logic of the arguments behind them and substantial evidence that they do not work.
Health Policy · 2025-05-18 · 14 citations
reviewOpen access1st authorCorresponding• The Trump administration presents European health with threats and opportunities. • We analyse impacts of U.S. actions on health financing, resources, and governance. • Cuts to US research, foreign aid, and WHO role create opportunities for Europe. • US actions threaten health finance, research, governance, and supply chains. • EU-European divergence could create risks. The second Trump administration has already made major changes in US policies that affect health and health systems worldwide. We use the Health Systems Performance Assessment categories developed by the European Observatory on Health Systems and Policies to identify areas in which US actions affect the health systems and policies of European states and the EU, and presidential Executive Orders supplemented by campaign statements to understand US actions. We identify relevant US policies in the areas of finance, resource generation (regulation, vaccines, artificial intelligence, workforce, research, education) and governance (geopolitical turbulence, climate change, US departure from the World Health Organization, and foreign aid). We then identify opportunities for states or the EU to strengthen their health systems, potential threats that might arise to their health systems from US actions, and serious confirmed threats. The second Trump administration is creating heavy demands on European governments in many areas, which might undermine their fiscal capacity and willingness to fund health systems or new ventures, but diminished US investment in areas such as multilateralism, pandemic response, research, education, and aid (especially in areas such as gender and reproductive health) all create opportunities for European policymakers to strengthen their health systems, health-related economic sectors, and influence in global health governance.
Trump's second presidency begins: evaluating effects on the US health system
The Lancet Regional Health - Americas · 2025-07-04 · 20 citations
reviewOpen access1st authorCorrespondingThe first hundred days of the second Trump administration was unprecedented, with the administration taking remarkably aggressive, often questionably legal actions across health policy. This article uses the Health Systems Performance Assessment Framework to identify key policies regarding resources, financing, governance, and service delivery and their impact on the cost, quality, access, and equity of the US health system. The evaluation is largely negative. The administration, in its very energetic first hundred days, has already undermined resources, financing, and in particular governance in areas as diverse as oversight of long-term care, scientific research, and vaccination policy. Administration rhetoric and budget proposals called for severe reductions in health care access and actions to terminate services for particular groups, such as immigrants or gender minorities. Many of the particular actions, such as mass layoffs of specialist scientific and regulatory staff, will be difficult to reverse.
Co-benefits of health: from evidence to governance, politics and advocacy
European Journal of Public Health · 2025-12-16
articleOpen accessTrump and the future of health services research and policy in Europe: A view from the US
Journal of Health Services Research & Policy · 2025-07-07
editorial1st authorCorrespondingThe antivaccine movement threatens health in the US and worldwide
BMJ · 2025-07-03 · 3 citations
editorialOpen accessSenior authorRobert F Kennedy Jr and others in the antivaccine movement are using the power of the US government to promote disinformation and flawed science, write <b>Anna Kirkland</b> and <b>Scott Greer</b>
EURO-DOGE by stealth? Concerning developments in the (de)funding of European health civil society
European Journal of Public Health · 2025-07-08 · 1 citations
articleOpen accessSenior authorThe future of global health, without the United States
Bulletin of the Atomic Scientists · 2025-05-04 · 3 citations
article1st authorCorrespondingPerspectives on Politics · 2025-03-21
article1st authorCorrespondingWhat Can Be Done About the Global Far Right’s Threat to Health?
American Journal of Public Health · 2025-05-14 · 3 citations
editorialOpen access1st authorCorresponding
Recent grants
Implementing Supranational Justice: Policymakers and the European Court of Justice
NSF · $156k · 2008–2010
Frequent coauthors
- 59 shared
Holly Jarman
University of Michigan–Ann Arbor
- 47 shared
Michelle Falkenbach
European Observatory on Health Systems and Policies
- 22 shared
Matthias Wismar
European Observatory on Health Systems and Policies
- 20 shared
Benjamin D. Trump
United States Army Corps of Engineers
- 17 shared
Peter Donnelly
University of St Andrews
- 15 shared
Igor Linkov
U.S. Army Engineer Research and Development Center
- 15 shared
Jane Gingrich
- 14 shared
Sarah Rozenblum
Cornell University
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Scott L. Greer
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup